BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bastiaannet R, Kappadath SC, Kunnen B, Braat AJAT, Lam MGEH, de Jong HWAM. The physics of radioembolization. EJNMMI Phys 2018;5:22. [PMID: 30386924 DOI: 10.1186/s40658-018-0221-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Dietze MMA, de Jong HWAM. Progress in large field-of-view interventional planar scintigraphy and SPECT imaging. Expert Rev Med Devices 2022;:1-11. [PMID: 35695477 DOI: 10.1080/17434440.2022.2088355] [Reference Citation Analysis]
2 Ahmadzadehfar H, Ilhan H, Lam MGEH, Sraieb M, Stegger L. Radioembolization, Principles and indications. Nuklearmedizin 2022;61:262-72. [PMID: 35354218 DOI: 10.1055/a-1759-4238] [Reference Citation Analysis]
3 Stella M, Braat AJAT, Lam MGEH, de Jong HWAM, van Rooij R. 166Holmium-99mTechnetium dual-isotope imaging: scatter compensation and automatic healthy-liver segmentation for 166Holmium radioembolization dosimetry. EJNMMI Phys 2022;9:30. [PMID: 35445948 DOI: 10.1186/s40658-022-00459-x] [Reference Citation Analysis]
4 d’Abadie P, Walrand S, Lhommel R, Hesse M, Borbath I, Jamar F. Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria. Current Oncology 2022;29:2422-34. [DOI: 10.3390/curroncol29040196] [Reference Citation Analysis]
5 Chan H, Lo Y, Chang D, Li J, Chang W, Chen C, Chang C, Chen C, Wang H, Liu R, Wu C. Radiometal-Labeled Chitosan Microspheres as Transarterial Radioembolization Agents against Hepatocellular Carcinoma. Gels 2022;8:180. [DOI: 10.3390/gels8030180] [Reference Citation Analysis]
6 Tang X, Jafargholi Rangraz E, Heeren R, Coudyzer W, Maleux G, Baete K, Verslype C, Gooding MJ, Deroose CM, Nuyts J. Segmentation-guided multi-modal registration of liver images for dose estimation in SIRT. EJNMMI Phys 2022;9. [DOI: 10.1186/s40658-022-00432-8] [Reference Citation Analysis]
7 Keane G, Lam M, de Jong H. Beyond the MAA-Y90 Paradigm: The Evolution of Radioembolization Dosimetry Approaches and Scout Particles. Semin Intervent Radiol 2021;38:542-53. [PMID: 34853500 DOI: 10.1055/s-0041-1736660] [Reference Citation Analysis]
8 Zijlema SE, Branderhorst W, Bastiaannet R, Tijssen RHN, Lagendijk JJW, van den Berg CAT. Minimizing the need for coil attenuation correction in integrated PET/MRI at 1.5 T using low-density MR-linac receive arrays. Phys Med Biol 2021;66. [PMID: 34571496 DOI: 10.1088/1361-6560/ac2a8a] [Reference Citation Analysis]
9 Plachouris D, Tzolas I, Gatos I, Papadimitroulas P, Spyridonidis T, Apostolopoulos D, Papathanasiou N, Visvikis D, Plachouri KM, Hazle JD, Kagadis GC. A deep-learning-based prediction model for the biodistribution of 90 Y microspheres in liver radioembolization. Med Phys 2021;48:7427-38. [PMID: 34628667 DOI: 10.1002/mp.15270] [Reference Citation Analysis]
10 Depalo T, Traino AC, Bargellini I, Lorenzoni G, Bozzi E, Vivaldi C, Lamastra R, Masi G, Cioni R, Boni G, Volterrani D. Assessment of radiation sensitivity of unresectable intrahepatic cholangiocarcinoma in a series of patients submitted to radioembolization with yttrium-90 resin microspheres. Sci Rep 2021;11:19745. [PMID: 34611210 DOI: 10.1038/s41598-021-99219-7] [Reference Citation Analysis]
11 Georgiou MF, Kuker RA, Studenski MT, Ahlman PP, Witte M, Portelance L. Lung shunt fraction calculation using 99mTc-MAA SPECT/CT imaging for 90Y microsphere selective internal radiation therapy of liver tumors. EJNMMI Res 2021;11:96. [PMID: 34585259 DOI: 10.1186/s13550-021-00837-z] [Reference Citation Analysis]
12 d'Abadie P, Walrand S, Hesse M, Amini N, Lhommel R, Sawadogo K, Jamar F. Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres. Phys Med 2021;89:250-7. [PMID: 34438353 DOI: 10.1016/j.ejmp.2021.07.032] [Reference Citation Analysis]
13 Stein SI, Soliman MM, Sparapani J, Doustaly R, Cobb BW, Malhotra A, Charalel R, May BJ, Lee KS, Madoff DC, Talenfeld AD. Conventional Hepatic Volumetry May Lead to Inaccurate Segmental Yttrium-90 Radiation Dosimetry. Cardiovasc Intervent Radiol 2021;44:1973-85. [PMID: 34414494 DOI: 10.1007/s00270-021-02898-y] [Reference Citation Analysis]
14 d'Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects. Molecules 2021;26:3966. [PMID: 34209590 DOI: 10.3390/molecules26133966] [Reference Citation Analysis]
15 Van BJ, Dewaraja YK, Sangogo ML, Mikell JK. Y-90 SIRT: evaluation of TCP variation across dosimetric models. EJNMMI Phys 2021;8:45. [PMID: 34114115 DOI: 10.1186/s40658-021-00391-6] [Reference Citation Analysis]
16 Lu Z, Chen G, Lin KH, Wu TH, Mok GSP. Evaluation of different CT maps for attenuation correction and segmentation in static 99m Tc-MAA SPECT/CT for 90 Y radioembolization treatment planning: A simulation study. Med Phys 2021;48:3842-51. [PMID: 34013551 DOI: 10.1002/mp.14991] [Reference Citation Analysis]
17 Sarrut D, Bała M, Bardiès M, Bert J, Chauvin M, Chatzipapas K, Dupont M, Etxebeste A, Fanchon LM, Jan S, Kayal G, Kirov AS, Kowalski P, Krzemien W, Labour J, Lenz M, Loudos G, Mehadji B, Ménard L, Morel C, Papadimitroulas P, Rafecas M, Salvadori J, Seiter D, Stockhoff M, Testa E, Trigila C, Pietrzyk U, Vandenberghe S, Verdier MA, Visvikis D, Ziemons K, Zvolský M, Roncali E. Advanced Monte Carlo simulations of emission tomography imaging systems with GATE. Phys Med Biol 2021;66. [PMID: 33770774 DOI: 10.1088/1361-6560/abf276] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Henry EC, Strugari M, Mawko G, Brewer KD, Abraham R, Kappadath SC, Syme A. Post-administration dosimetry in yttrium-90 radioembolization through micro-CT imaging of radiopaque microspheres in a porcine renal model. Phys Med Biol 2021;66. [PMID: 33784639 DOI: 10.1088/1361-6560/abf38a] [Reference Citation Analysis]
19 Roosen J, Klaassen NJM, Westlund Gotby LEL, Overduin CG, Verheij M, Konijnenberg MW, Nijsen JFW. To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer. Eur J Nucl Med Mol Imaging 2021. [PMID: 33839892 DOI: 10.1007/s00259-021-05340-0] [Reference Citation Analysis]
20 d'Abadie P, Walrand S, Hesse M, Annet L, Borbath I, Van den Eynde M, Lhommel R, Jamar F. Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. Nucl Med Commun 2021;42:747-54. [PMID: 33741864 DOI: 10.1097/MNM.0000000000001395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Nodari G, Popoff R, Riedinger JM, Lopez O, Pellegrinelli J, Dygai-Cochet I, Tabouret-Viaud C, Presles B, Chevallier O, Gehin S, Gallet M, Latournerie M, Manfredi S, Loffroy R, Vrigneaud JM, Cochet A. Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapy. EJNMMI Res 2021;11:24. [PMID: 33687596 DOI: 10.1186/s13550-021-00766-x] [Reference Citation Analysis]
22 Plachouris D, Mountris KA, Papadimitroulas P, Spyridonidis T, Katsanos K, Apostolopoulos D, Papathanasiou N, Hazle JD, Visvikis D, Kagadis GC. Clinical Evaluation of a Three-Dimensional Internal Dosimetry Technique for Liver Radioembolization with 90Y Microspheres Using Dose Voxel Kernels. Cancer Biother Radiopharm 2021. [PMID: 33656372 DOI: 10.1089/cbr.2020.4554] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Alsultan AA, Braat AJAT, Smits MLJ, Barentsz MW, Bastiaannet R, Bruijnen RCG, de Keizer B, de Jong HWAM, Lam MGEH, Maccauro M, Chiesa C. Current Status and Future Direction of Hepatic Radioembolisation. Clin Oncol (R Coll Radiol) 2021;33:106-16. [PMID: 33358630 DOI: 10.1016/j.clon.2020.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Craig AJ, Rojas B, Wevrett JL, Hamer E, Fenwick A, Gregory R. IPEM topical report: current molecular radiotherapy service provision and guidance on the implications of setting up a dosimetry service. Phys Med Biol 2020;65:245038. [PMID: 33142274 DOI: 10.1088/1361-6560/abc707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
25 Kao YH. Dose-response for yttrium-90 resin microsphere radioembolisation. Nucl Med Commun 2021;42:345-7. [PMID: 33346604 DOI: 10.1097/MNM.0000000000001351] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Villalobos A, Soliman MM, Majdalany BS, Schuster DM, Galt J, Bercu ZL, Kokabi N. Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know. Semin Intervent Radiol 2020;37:543-54. [PMID: 33328711 DOI: 10.1055/s-0040-1720954] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 McGregor H, Brunson C, Woodhead G, Khan A, Hennemeyer C, Patel M. Quantitative Assessment of the Hemodynamic Effects of Intra-Arterial Nitroglycerin on Hepatocellular Carcinoma using Two-Dimensional Perfusion Angiography. J Vasc Interv Radiol 2021;32:198-203. [PMID: 33279371 DOI: 10.1016/j.jvir.2020.10.023] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 van Roekel C, Harlianto NI, Braat AJAT, Prince JF, van den Hoven AF, Bruijnen RCG, Lam MGEH, Smits MLJ. Evaluation of the Safety and Feasibility of Same-Day Holmium-166 -Radioembolization Simulation and Treatment of Hepatic Metastases. J Vasc Interv Radiol 2020;31:1593-9. [PMID: 32861571 DOI: 10.1016/j.jvir.2020.01.032] [Reference Citation Analysis]
29 Jafargholi Rangraz E, Tang X, Van Laeken C, Maleux G, Dekervel J, Van Cutsem E, Verslype C, Baete K, Nuyts J, Deroose CM. Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definition. EJNMMI Res 2020;10:94. [PMID: 32797332 DOI: 10.1186/s13550-020-00675-5] [Reference Citation Analysis]
30 Hectors SJ, Lewis S, Kennedy P, Bane O, Said D, Segall M, Schwartz M, Kim E, Taouli B. Assessment of Hepatocellular Carcinoma Response to 90Y Radioembolization Using Dynamic Contrast Material-enhanced MRI and Intravoxel Incoherent Motion Diffusion-weighted Imaging. Radiol Imaging Cancer 2020;2:e190094. [PMID: 32803165 DOI: 10.1148/rycan.2020190094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Stella M, Braat A, Lam M, de Jong H, van Rooij R. Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible. EJNMMI Phys 2020;7:48. [PMID: 32666401 DOI: 10.1186/s40658-020-00317-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Reinders M, Braat A, Lam M. Toxicity and dosimetry in SORAMIC study. J Hepatol 2020;73:734-5. [PMID: 32622664 DOI: 10.1016/j.jhep.2020.03.045] [Reference Citation Analysis]
33 Mikell JK, Dewaraja YK, Owen D. Transarterial Radioembolization for Hepatocellular Carcinoma and Hepatic Metastases: Clinical Aspects and Dosimetry Models. Semin Radiat Oncol 2020;30:68-76. [PMID: 31727302 DOI: 10.1016/j.semradonc.2019.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
34 Tang X, Jafargholi Rangraz E, Coudyzer W, Bertels J, Robben D, Schramm G, Deckers W, Maleux G, Baete K, Verslype C, Gooding MJ, Deroose CM, Nuyts J. Whole liver segmentation based on deep learning and manual adjustment for clinical use in SIRT. Eur J Nucl Med Mol Imaging 2020;47:2742-52. [DOI: 10.1007/s00259-020-04800-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
35 Braat AJAT, Bruijnen RCG, van Rooij R, Braat MNGJA, Wessels FJ, van Leeuwaarde RS, van Treijen MJC, de Herder WW, Hofland J, Tesselaar MET, de Jong HWAM, Lam MGEH. Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study. Lancet Oncol 2020;21:561-70. [PMID: 32112737 DOI: 10.1016/S1470-2045(20)30027-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
36 Kunnen B, Dietze MMA, Braat AJAT, Lam MGEH, Viergever MA, de Jong HWAM. Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning. Med Phys 2020;47:1105-14. [PMID: 31855282 DOI: 10.1002/mp.13974] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
37 Bastiaannet R, van der Velden S, Lam MGEH, Viergever MA, de Jong HWAM. Fast and accurate quantitative determination of the lung shunt fraction in hepatic radioembolization. Phys Med Biol 2019;64:235002. [DOI: 10.1088/1361-6560/ab4e49] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Bastiaannet R, van Roekel C, Smits ML, Elias SG, van Amsterdam WA, Doan D, Prince JF, Bruijnen RC, de Jong HW, Lam MG. First Evidence for a Dose–Response Relationship in Patients Treated with 166 Ho Radioembolization: A Prospective Study. J Nucl Med 2020;61:608-12. [DOI: 10.2967/jnumed.119.232751] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
39 Seifert R, Kessel K, Boegemann M, Köhler M, Roll W, Stegger L, Weckesser M, Rahbar K. Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy. J Nucl Med 2020;61:723-8. [PMID: 31601703 DOI: 10.2967/jnumed.119.233429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
40 Bastiaannet R, Lodge MA, de Jong HW, Lam MG. The Unique Role of Fluorodeoxyglucose-PET in Radioembolization. PET Clinics 2019;14:447-57. [DOI: 10.1016/j.cpet.2019.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 van Roekel C, Reinders MT, van der Velden S, Lam MG, Braat MN. Hepatobiliary Imaging in Liver-directed Treatments. Seminars in Nuclear Medicine 2019;49:227-36. [DOI: 10.1053/j.semnuclmed.2019.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Jafargholi Rangraz E, Coudyzer W, Maleux G, Baete K, Deroose CM, Nuyts J. Multi-modal image analysis for semi-automatic segmentation of the total liver and liver arterial perfusion territories for radioembolization. EJNMMI Res 2019;9:19. [PMID: 30788640 DOI: 10.1186/s13550-019-0485-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]